Fluidigm Maxpar Direct Immune Profiling System
Fluidigm has launched the Maxpar Direct Immune Profiling System, which enables researchers to quantify 37 different immune cell populations from human peripheral blood mononuclear cells and whole blood using a simple automated single-tube workflow in five minutes. The new system provides a more comprehensive immune cell profile from both PBMC and whole blood and a user workflow that is significantly improved from the company's Maxpar Human Immune Monitoring Panel Kit. The system contains a 30-marker antibody panel that was developed with input from expert immunologists from academia and biopharma to identify and count 37 different immune cell subsets. Provided in a dry format in ready-to-use assay tubes, it enables researchers to easily stain samples and acquire results using the Fluidigm Helios mass cytometry system, the company said. Researchers can also add up to seven new antibodies to the panel to support specific study goals. Automated single-cell selection and results reporting is completed in just five minutes using the Maxpar Pathsetter software, developed with Verity Software House, Fluidigm said.